Is There a Cure for Mediocre Pharma Mobile Apps?: Listen Up, New Marketing Grads!
Mobile is the new 'shiny thing' of interest to pharmaceutical marketers. However, most pharma mobile apps that I have seen are pretty mundane as far as marketing/advertising is concerned. What's it going to take to make these apps more interesting and useful?
Pharma Marketing News Vol. 11, No. 11: 27 December 2012
Welcome to Volume 11, Issue #11 (27 December 2012) of Pharma Marketing News.
Pharma Marketing News Vol. 11, No. 3: 19 March 2012
Welcome to Volume 11, Issue #3 (19 MARCH 2012) of Pharma Marketing News.
Who Owns Your Social Media?
Twitter's new rules change the playing field for third party developers, establish caps on number of users, and shift guidelines to requirements across four categories of businesses. Will the new rules ruin the spirit of social media and are they bad for healthcare?
FDA Social Media Guidelines May Be Moot: If This Court Decision Holds Up
Drugmakers dissatisfied with the FDA's use of guidances as a form of policymaking -- including long-awaited guidance for use of social media by the pharmaceutical industry -- could find legal ammunition against the practice. This article presents the relevant case information.
Pharma Marketing News Vol. 11, No. 7: 26 July 2012
Welcome to Volume 11, Issue #7 (26 JULY 2012) of Pharma Marketing News.
Is Online Pharma Advertising ROI Scalable? Outsize Results on Modest Spends May Not Scale...
At the recent 6th Annual Digital Pharma East conference in Philadelphia, Bill Drummy, CEO of HeartBeat Ideas, argued that 'With digital you can get way more bang for your buck, so you HAVE to think of the digital channel.' Drummy's message was simple: the ROI of online promotion is an order of magnitude greater than the "typical" 2:1 ROI for non-digital channel promotion. This may be true of small budget campiagns, but is it scaleable to the point where digital promotion gives you a significant bump in sales?
Pharma Marketing News Vol. 11, No. 4: 19 April 2012
Welcome to Volume 11, Issue #4 (19 APRIL 2012) of Pharma Marketing News.
Do Drug Copay Coupons Drive Up Healthcare Costs?
Coupons for drug co-payments are illegal and drive up long-term health-care costs for all, a consumer group and four trade-union health-insurance plans said in announcing lawsuits against eight pharmaceutical companies. The lawsuits claim that although coupons reduce the consumer's out-of-pocket cost, the health insurer still pays the previously negotiated price to the drug company. With no savings from generics, health plans will need to charge patients more to keep up with rising costs, the lawsuits say.
Gamification: Now and Then
There's a lot of brouhaha these days in pharma circles about 'gamification' as if it were the newest thing since sliced bread. These days, however, it may be easier for a pharma company to create a real-life museum educational gaming experience than a virtual world game on Facebook. Way back in 1984, gamification was much simpler.
